Tolvaptan 30 MG tablet UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,379
Award facts
- Contract value 100% obligated
- $4,378.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,378.71 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packaging of 10s. This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor with a demonstrated track record of efficiently fulfilling government contracts for essential pharmaceutical commodities. The company's fulfillment operations are based at the place of performance in Conshohocken, Pennsylvania, and the firm consistently delivers medications across diverse therapeutic areas to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Tolvaptan, a medication used in treating hyponatremia, reflects the company's established capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F0ZM8?
SPE2DR26F0ZM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F0ZM8 worth?
The government has obligated $4,379 on SPE2DR26F0ZM8.
Is contract SPE2DR26F0ZM8 an order under another contract?
Yes. SPE2DR26F0ZM8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZM8 competed?
The extent of competition for SPE2DR26F0ZM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award